Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4339903

N.O=C(O)OC12CC3CC(CC(C3)C1)C2

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 4/20 0.42
EPHX2 P34913 2/20 0.41
NPSR1 Q6W5P4 3/20 0.40
NAAA Q02083 1/20 0.40
THRB P10828 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP17A1 P05093 3/20 0.38
EPHX1 P07099 1/20 0.38
CA2 P00918 1/20 0.36
TSHR P16473 1/20 0.36
GAA P10253 1/20 0.34
GLA P06280 1/20 0.34
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 1/20 0.34
HTT P42858 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL865316 0.98 CYP19A1 (0.43) CYP19A1EPHX2NPSR1NAAATHRB
SCHEMBL6207794 0.82 MEN1 (0.43) CYP19A1EPHX2NPSR1NAAACYP17A1
SCHEMBL865315 0.80 NPSR1 (0.48) CYP19A1EPHX2NPSR1NAAATHRB
SCHEMBL27736443 0.80 CYP19A1 (0.44) CYP19A1EPHX2NPSR1NAAATHRB
SCHEMBL7183809 0.79 CYP19A1 (0.41) CYP19A1EPHX2NPSR1NAAATHRB
SCHEMBL4222114 0.78 CYP19A1 (0.43) CYP19A1EPHX2NPSR1NAAATHRB
SCHEMBL282761 0.78 THRB (0.31) THRBCYP2C9
SCHEMBL2212076 0.78 CYP19A1 (0.43) CYP19A1EPHX2NPSR1NAAATHRB
SCHEMBL27240 0.76 NPSR1 (0.45) CYP19A1EPHX2NPSR1NAAACYP17A1
SCHEMBL2517522 0.76 CYP19A1 (0.42) CYP19A1EPHX2NPSR1NAAATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090246233-A1 Treatment of Gastroparesis and Nonulcer Dyspepsia With GABAB Agonists AGI THERAPEUTICS RESEARCH LTD. 2009-10-01 US disclosed
EP-1675581-A1 TREATMENT OF GASTROPARESIS AND NONULCER DYSPEPSIA WITH GABA-b AGONISTS AGI THERAPEUTICS RESEARCH LIMITED (IE) 2006-07-05 EP disclosed
US-20050090554-A1 Administering baclofen, or a salt thereof, to relieve at least one symptom of gastroparesis other than vomiting AGI THERAPEUTICS LTD. (IE) 2005-04-28 US disclosed
WO-2005025559-A1 TREATMENT OF GASTROPARESIS AND NONULCER DYSPEPSIA WITH GABAB AGONISTS AGI THERAPEUTICS LTD. (US) 2005-03-24 WO disclosed